Effects of Curcumin Supplementation in Patients With Chronic Kidney Disease on Peritoneal Dialysis
Launched by UNIVERSIDADE FEDERAL FLUMINENSE · May 28, 2020
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Curcumin is a chemical compound of the curcuminoids class found in the root of Curcuma (Curcuma longa), and due to its potential antioxidant and anti-inflammatory, has been suggested as a nutritional strategy to reduce oxidative stress and inflammation present in several chronic diseases. Although it is a promising therapy, there are no studies evaluating the effects of curcumin in patients with chronic kidney disease (CKD) in peritoneal dialysis (PD). The aim of this study is to evaluate the effect of curcumin supplementation on inflammatory markers and oxidative stress in patients with CK...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of Chronic Kidney Disease
- • Peritoneal dialysis patients for more than 6 months
- • Aged from 18 to 60 years
- • Must be able to swallow tablets
- Exclusion Criteria:
- • Patients pregnant
- • Smokers
- • Using antibiotics in the last 3 months
- • Using antioxidant supplements in the last 3 months
- • Usual intake of turmeric
- • Usual intake Autoimmune
- • Clinical diagnosis of infectious diseases
- • Clinical diagnosis of Cancer
- • Clinical diagnosis of AIDS
Trial Officials
Denise Mafra, Ph.D
Principal Investigator
Federal University Fluminense
About Universidade Federal Fluminense
Universidade Federal Fluminense (UFF) is a prestigious Brazilian public university renowned for its commitment to academic excellence and innovation in research. As a clinical trial sponsor, UFF leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The institution fosters collaboration between researchers, healthcare professionals, and industry partners, ensuring rigorous ethical standards and adherence to regulatory requirements in the conduct of clinical trials. UFF's dedication to scientific inquiry and community health positions it as a leading contributor to the advancement of clinical research in Brazil and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rio De Janeiro, Rj, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
